Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Ronald Bradley Demattos0
Michael Carl Irizarry0
Date of Patent
April 26, 2022
0Patent Application Number
163106290
Date Filed
June 23, 2017
0Patent Primary Examiner
The invention is directed to a short term induction treatment with anti-N3pGlu Aβ antibodies of a disease characterized by deposition of Aβ in the brain, that include Alzheimer's disease (AD), Down's syndrome, and cerebral amyloid angiopathy (CAA). In certain embodiments, patients are administered an induction dose of 10 to 60 mg/kg of an anti-N3pGlu Aβ antibody for a period of 6 months or less.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
